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The ability of bacteriophages to kill bacteria is well known, as is their potential use as alternatives to 
antibiotics. As such, bacteriophages reach high doses locally through infection of their bacterial host in 
the human body. In this study we assessed the gene expression profile of peripheral blood monocytes 
from six donors for twelve immunity-related genes (i.e. CD14, CXCL1, CXCL5, IL1A, IL1B, IL1RN, IL6, 
IL10, LYZ, SOCS3, TGFBI and TNFA) induced by Staphylococcus aureus phage ISP and four Pseudomonas 
aeruginosa phages (i.e. PNM, LUZ19, 14-1 and GE-vB_Pae-Kakheti25). The phages were able to 
induce clear and reproducible immune responses. Moreover, the overall immune response was very 
comparable for all five phages: down-regulation of LYZ and TGFBI, and up-regulation of CXCL1, CXCL5, 
IL1A, IL1B, IL1RN, IL6, SOCS3 and TNFA. The observed immune response was shown to be endotoxin-
independent and predominantly anti-inflammatory. Addition of endotoxins to the highly purified 
phages did not cause an immune response comparable to the one induced by the (endotoxin containing) 
phage lysate. In addition, the use of an intermediate level of endotoxins tipped the immune response 
to a more anti-inflammatory response, i.e. up-regulation of IL1RN and a strongly reduced expression of 
CXCL1 and CXCL5.
Bacteriophages are the most abundant entities, impacting ecological niches ranging from the ocean to the gut 
microbiome1–5. Furthermore, it is known that phages are immensely specific towards a specific bacterial host 
without infect other bacterial strains. Moreover, there is currently no data available of phages infecting eukaryotic 
cells. This makes them ideal candidates to treat bacterial infections, while being harmless to mammalian cells and 
even non-target bacteria6.
Bacteria that inhabit the intestine and skin are generally regarded as stable residents that may confer metabolic 
and/or immune benefits to their hosts7. The host immune system has evolved mechanisms to tolerate these com-
mensal organisms while at the same time providing protection for the host from pathogens8. Similarly, metagen-
omic studies have revealed that a vast variety of bacteriophages are associated with healthy human tissues9–11. In 
case of phages, a persistent nonpathogenic association seems possible as viral replication occurs only in bacterial 
hosts, which can themselves be stable members of the microbiome12.
It has been demonstrated that oral uptake of phages by animals results in the translocation of phages to sys-
temic tissues13, 14. This suggests that mammals have mechanisms for the uptake and delivery of phages from the 
gut to the blood. The contact between systemic tissues and phages may allow intestinal phages to elicit innate 
and adaptive immune responses. One possible uptake route involves dendritic cells, which are known to sample 
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intestinal luminal contents and can actively phagocytize phage particles in culture15, 16. It is also interesting to 
consider whether phages might elicit antiviral innate immune responses. Mammalian cells are endowed with the 
ability to detect viral nucleic acids through several pattern-recognition receptors that are positioned to detect 
viral entry into cells12.
A study performed by Weber-Dabrowska et al.17 demonstrated that phage therapy can normalize TNF-α 
serum levels and the production of TNF-α and IL6 by blood cell cultures. Miernikiewicz et al.18) performed an 
extensive study of the immunological effects of phage T4 and its head surface proteins. They found that phage T4 
and its surface proteins gp23*, gp24*, Hoc and Soc did not affect production of the inflammatory cytokine and 
ROS production. Recently Majewska et al.19 followed the antibody production (i.e. IgM, IgG and secretory IgA) 
after oral application of phage T4 to mice. However, the orally applied phage T4 induced anti-phage antibodies 
only after a combination of long exposure times (i.e. IgG day 36 and IgA day 79) and high doses.
The use of phage therapy has persisted without interruption in Eastern Europe, particularly in centers such 
as the Eliava Institute of Bacteriophage, Microbiology and Virology in Tbilisi, Georgia and the Institute of 
Immunology and Experimental Therapy in Wroclaw, Poland20, 21. Phage interactions with animals in general and 
human beings in particular have been comprehensively reviewed21, and there have been no reports of significant 
adverse reactions despite their long history of administration to humans.
Here, we report on the immune response induced by individual (highly purified) phages. It has previously 
been described that CsCl gradient ultra-centrifuged phages are free from residual DNA, RNA and bacterial pro-
teins released during the lysis of the bacterial cell22. Hence the immune responses observed in our study are 
induced by the phages. We conducted a whole transcriptome analysis of human peripheral blood mononuclear 
cells (PBMCs) stimulated with either P. aeruginosa or a P. aeruginosa phage PNM lysate. The P. aeruginosa phage 
PNM lysate condition most closely reflects the immunological condition obtained during phage therapy, when 
the phage titer is the highest and predominantly bacterial fragments, from the lysed bacterial cells, remain. These 
data suggest that certain immunological pathways are activated during and/or after phage therapy and may con-
tribute to the efficacy of phages during phage therapy. Next, to understand to what extent the phage particles 
interact with the human immune system, the immune response induced by two different phage purification strat-
egies (i.e. either a phage lysate or a highly purified phage) was compared. Using twelve immunity-related genes, 
the immune response induced by five different phages were compared, four infecting P. aeruginosa and one S. 
aureus phage. These five phages represent the three major phage morphologies (Table 1). This might give us an 
idea whether the immune response might be phage host specific or phage morphology dependent.
Results
RNA transcriptome analysis of peripheral blood mononuclear cells. Peripheral blood mononuclear 
cells (PBMCs) derived from one donor were stimulated in triplicate with either saline, 0.1 cfu/PBMC of P. aerug-
inosa strain 573 or 103 pfu/PBMC of P. aeruginosa phage PNM, during 20 h. An average of 47 million reads was 
obtained for the unstimulated and stimulated PBMCs, after cleaning and quality checks were carried out. Of the 
total number of reads, approximately 85% could be mapped to the human genome (Table S1).
Transcriptome analysis of the unstimulated PBMCs versus P. aeruginosa strain 573 revealed a total of 996 
up-regulated genes and 1377 down-regulated genes compared to 704 up-regulated and 392 down-regulated 
genes when the PBMCs were stimulated with P. aeruginosa phage PNM (Tables S2 and S3). Many of the genes 
that are differentially expressed play important roles in immunity-related processes. For example, the Major 
Histocompatibility Class (MHC) II genes HLA-DMA, HLA-DMB, HLA-DRB1 and HLA-DRB4 were signifi-
cantly down-regulated after phage PNM stimulation. In case of PBMCs stimulated with P. aeruginosa, our results 
suggest that most of the genes involved in the antigen presentation by MHC I and MHC II are not differen-
tially expressed, with exception of HLA-DRB4 (Log2 fold change of −1.00) and HLA-L (Log2 fold change of 
1.02). CD1c is also significantly down-regulated in the P. aeruginosa phage PNM dataset. The CD1 molecules are 
MHC-like proteins that bind β2 microglobulin but, in contrast to MHC class I, their principal domain of action 
is in the endocytic pathway23.
An observation that might play a crucial role in the immune response against the bacterial host of phage 
PNM, i.e. P. aeruginosa, is the down-regulation of Toll-like receptor 4 (TLR4). Toll-like receptor 4 is a classic 
Bacteriophage Phage family Bacterial Host
Titer (pfu/ml) Endotoxins (EU/ml)
Reference Isolated by Isolation dateLysate
Higly 
purified Lysate
Higly 
purified
P. aeruginosa phage 
PNM Podoviridae
P. aeruginosa 
strain 573 1.8 × 10
13 3.0 × 1013 3.1 × 106 6.6 × 103 Merabishvili et al.54 N. Lashki & M. Tediashvili 1999
P. aeruginosa phage 
LUZ19 Podoviridae
P. aeruginosa 
strain 573 5.0 × 10
13 5.0 × 1011 3.1 × 104 4.2 × 103 Lammens et al.66 P. J. Ceyssens 2006
P. aeruginosa phage 
GE-vB_Pae-Kakheti25 Siphoviridae
P. aeruginosa 
strain 573 2.5 × 10
12 9.0 × 1010 7.5 × 106 1.3 × 103 Karumidze et al.67 N. Kvatadze 2012
P. aeruginosa phage 
14-1 Myoviridae
P. aeruginosa 
strain 573 3.6 × 10
12 5.0 × 1012 3.3 × 105 3.5 × 104 Ceyssens et al.68 V. Krylov 2000
S. aureus phage ISP Myoviridae S. aureus strain ATCC 6538 2.0 × 10
11 1.4 × 1011 0.0 0.0 Vandersteegen et al.69 Unknown 1920–1930
Table 1. Different phages used in the different purification strategies. For each phage, taxonomical family and 
bacterial host strain are presented, as well as the titer of the phage lysates, before and after endotoxin removal.
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member of the TLR superfamily and has been studied extensively in pathogen-mediated host responses and func-
tions as a primary sensor to detect LPS, a component of Gram-negative bacteria such as P. aeruginosa24. TLR4 
activation induces secretion of pro-inflammatory molecules such as chemokines and cytokines which amplify the 
response to infection25, 26.
Both P. aeruginosa and phage PNM have the ability to down-regulate TLR4, a −3.9 Log2 fold change reduc-
tion and −1.3 Log2 fold change reduction, respectively. In addition, P. aeruginosa was able to down-regulate 
CD14 (Log2 fold change of −8.0) and lymphocyte antigen 96, encoded by the LY96 gene (Log2 fold change of 
−2.0), also known as MD2. Both genes play an important role as co-receptors of TLR4 in the recognition of 
Gram-negative LPS. Furthermore, it is interesting to note that lysozyme is strongly down-regulated after P. aerug-
inosa strain 573 stimulation and P. aeruginosa phage PNM (Log2 fold change of −7.8 and −3.3, respectively).
Besides the differential expression in the MHC class II genes, many cytokines were up- and down-regulated. 
Of the differentially expressed cytokines, the IL10 family cytokines (i.e. IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, 
IL-28A and IL-28B) are of particular interest for their anti-inflammatory properties and tissue protection27. IL-10, 
known for its interaction with leukocytes and its anti-inflammatory properties, had an up-regulation after phage 
PNM stimulation (Log2 fold change of 4.3), and after P. aeruginosa stimulation (Log2 ratio of 4.3).
IL-10 is an anti-inflammatory cytokine that inhibits the activity of TH1 cells, NK cells and macrophages28. It 
blocks the expression of pro-inflammatory cytokines, including TNF-α, IFN-γ, IL-1, IL-12, and CXC and CC 
chemokines. The suppression of these cytokines is clearly visible in our data, (Tables S2 and S3). It also suppresses 
MHC class II and co-stimulatory molecules CD80 and CD86 on macrophages, and it inhibits the generation 
of reactive oxygen and nitrogen intermediates from macrophages and neutrophils. Our data indicate a slight 
up-regulation of CD80 (Log2 ratio of 1.7 for phage PNM and Log2 fold change of 1.6 for P. aeruginosa) and a 
down-regulation of CD86 (Log2 ratio of −1.5 for phage PNM and Log2 fold change of −1.8 for P. aeruginosa).
The IL-20 subfamily cytokines, composed of IL-19, IL-20, IL-24 and IL-26, primarily acts on various epithelial 
cells and protects these cells from invasion by extracellular pathogens such as bacteria and yeast. Of these, IL-19 
(Log2 ratio of 3.1 for phage PNM and Log2 ratio of 2.77 for P. aeruginosa), IL-20 (Log2 ratio of 7.1 for phage 
PNM and Log2 ratio of 5.7 for P. aeruginosa) and IL-24 (Log2 ratio of 3.2 for phage PNM and Log2 ratio of 1.1 for 
P. aeruginosa) were differently expressed.
Interleukin-6 (IL-6, Log2 ratio of 6.6 for phage PNM, Log2 fold change of 6.4 for P. aeruginosa), origi-
nally considered to be a pro-inflammatory cytokine, has anti-inflammatory properties as well29. For instance, 
IL-6 inhibits neutrophil accumulation after lipopolysaccharide (LPS) injection and antagonizes the actions of 
interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) via induction of the soluble IL-1 receptor antagonist 
and the soluble TNF-α receptor30.
Suppressors of cytokine signaling (SOCS) protein are a family of eight intracellular proteins that control 
cytokine signaling by suppressing cytokine signal transduction process, i.e. SOCS-1 to -7 and cytokine-inducible 
SH2-containing protein (CIS). SOCS-1 and -3 specifically participate in regulation of Th1 and Th2 cytokine 
signaling31, 32. SOCS-1 (Log2 fold change of 1.9 for phage PNM and Log2 ratio of 1.4 for P. aeruginosa) is a key 
modulator of interferon-γ (IFN-γ) signaling. Mice lacking SOCS-1 exhibit deregulated responses to IFN-γ result-
ing in excessive T-cell activation and are hyper-responsive to viral infections33, 34. SOCS-3 (Log2 fold change of 
2.0, no differential expression for P. aeruginosa) functions to control IL-6 induced Th2-associated response via 
its receptor gp13035. In macrophages, SOCS-3 mediates IL-10 inhibition of TNF-α and nitric oxide production36. 
Induction of SOCS-3 is regulated via IL-6 receptor trans-signaling. The observation of increased IL-10 in SOCS-3 
over-expressed trophoblast after IL-6 challenge is in line with the concept of a pro-inflammatory role of IL-6 in 
trophoblasts and SOCS-3 signaling in regulation with cytokine production37.
When comparing both the P. aeruginosa strain 573 and P. aeruginosa phage PNM lysate data sets, 359 differ-
entially expressed genes could be identified which were exclusively present in the phage PNM stimulated dataset. 
Of these 359 differentially expressed genes, 117 were up-regulated whereas 242 were down-regulated (Table S4). 
Therefore, expression of these genes can be considered as uniquely caused by the phage, and not by contamina-
tion of the phage with bacterial antigens. To further deduce whether the phage has immune properties, RT-qPCR 
analysis was performed on RNA derived from the PBMCs of six donors, stimulated during 20 hours with different 
concentrations of phage lysates, endotoxin-purified phages (Table 1), bacterial host strains and/or endotoxins, for 
a selection of twelve immunity-related genes (Table S5; discussed below).
RT-qPCR validation of 12 immunity-related genes. Staphylococcus aureus phage ISP induced immune 
response. Stimulation of PBMCs, derived from six donors (each stimulated in triplicate), with either an S. aureus 
phage ISP lysate, the highly purified phage ISP (undiluted and 100-fold diluted), or the S. aureus host strain 
showed that the immune response within each condition was highly reproducible (Fig. 1). Diluting the highly 
purified phage ISP led to an almost complete reduction of the observed immune response, with the exception of 
TNFA and CXCL5 which have the same induction as the undiluted phage and IL1B and CXCL1 which are both 
up-regulated but are significantly different from the undiluted phage condition, i.e. up-regulated but significantly 
less strong than the undiluted phage. These clear titration effects indicate that sufficiently high phage titers (i.e. 
≥103 pfu/PBMC) are necessary in order to induce an immune response.
Interestingly, the highly purified phage ISP induced an almost identical response as its bacterial host strain 
(except for CXCL5, IL1RN, IL6 and IL10), whereas the phage lysate, still containing bacterial contamination, 
induced a much weaker overall response (except for CXCL1, CXCL5, IL1B, IL1RN and TNFA).
The highly purified phage ISP significantly (p-value < 0.05) up-regulates the CXCL1, IL1A, IL1B, IL1RN, IL6 
and TNFA genes and down-regulates CD14, LYZ and TGFBI compared to the phage lysate.
The immune response induced by the phage and its bacterial host (i.e. S. aureus strain 6538) also shows a 
strong down-regulation of the LYZ gene expression, in agreement with the transcriptome results (Fig. 1). The 
values between the transcriptome analyses and RT-qPCR were consistent (R² = 0.88).
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Influence of endotoxins on the phage-induced immune response. To determine whether the observed immune 
response was induced by the bacteriophage rather than by possible endotoxin contamination present in the phage 
lysate or purified phage (Table 1), PBMCs were stimulated with either S. aureus phage ISP alone, i.e. completely 
endotoxin free (Table 1), at concentrations of 103 pfu/PBMC, or in combination with different concentrations of 
a commercial endotoxin preparation (i.e. 0.1, 10−3 or 10−7 EU/PBMC).
The addition of up to 0.1 EU/PBMC to 103 pfu/PBMC of phage ISP did not lead to a significant difference in 
the immune response as induced by the phage alone (Figs 2A–C and S1–S3). However, the immune response 
induced by phage ISP at 103 pfu/PBMC (with or without endotoxins) differed significantly (p-value < 0.05) from 
the immune response induced by the endotoxins alone, for CXCL5, LYZ, TGFBI and TNFA. The combination of 
phage with endotoxins led to a stronger up-regulation of TNFA or stronger down-regulation of LYZ and TGFBI in 
comparison with endotoxins alone, whereas the expression of CXCL5 was reduced compared to endotoxin alone 
when a combination of phage ISP with endotoxins was used.
Lowering the endotoxin concentration added to phage ISP from 0.1 EU/PBMC to 10−3 EU/PBMC, resulted 
in a significant difference (p-value < 0.05) in the gene expression of CXCL1, CXCL5, IL1RN, LYZ, TNFA and 
TGFBI, between the phage ISP with endotoxins (i.e. 103 pfu and 10−3 EU/PBMC) and endotoxins alone (i.e. 10−3 
EU/PBMC). Of particular interest was the down-regulation of CXCL1 and CXCL5 when stimulation was carried 
out with both endotoxin and phage compared to 103 pfu of phage ISP/PBMC alone or 10−3 of EU/PBMC alone 
(Figs 2B and S2). Further reduction of the endotoxin concentration to 10−7 EU/PBMC did not significantly differ 
from the immune response induced by the phage alone, with the exception of CXCL1 and IL1A (Figs 2C and S3), 
which were less expressed when the PBMCs were challenged with 10−7 EU/PMBC added to the phage instead of 
when stimulated by the phage alone.
Lowering the phage concentration from 103 pfu/PBMC to 10 pfu/PBMC, in combination with 0.1, 10−3 or 
10−7 EU/PBMC led to an immune response more similar to the one induced by the endotoxin alone than the one 
induced by the phage alone (Fig. 2D–F).
P. aeruginosa phage PNM induced immune response. Comparable to the observations for S. aureus phage ISP, 
the immune response induced by the P. aeruginosa phage PNM lysate (at 105 pfu/PBMC) differs significantly 
(p-value < 0.05) from the one induced by the highly purified phage (at 105 pfu/PBMC). However, it was the P. 
aeruginosa phage PNM lysate-induced response that was most consistent with the response to its bacterial host 
strain (i.e. 0.1 cfu/ml), except for CD14, CXCL5, LYZ and TNFA. A significant difference in the induced immune 
response between the phage lysate and the purified phage could be observed for CXCL1, IL1A, IL1B, IL6, TNFA 
and TGFBI (Fig. 3A). Because this difference could be due to endotoxin contamination, we compared the stimu-
lation of the PBMCs with a highly purified phage PNM preparation with the addition of endotoxins (i.e. 0.1 EU/
PBMC), in order to equalize the endotoxin concentration with that of the phage lysate (0.3 EU/PBMC, Table 1). 
Nonetheless, this did not bring the observed immune response closer to the one induced by the phage lysate 
and even had the opposite effect for e.g. IL1A, IL6 and IL10 (Fig. 3A and B). This indicates that the difference in 
immune response induced by the highly purified phage compared to the phage lysate is not due to the presence 
of endotoxins in the phage lysate, but rather due to the presence of bacterial contaminants (e.g. bacterial DNA or 
proteins) in the phage lysate.
Immune response induced by P. aeruginosa phages PNM, LUZ19, 14-1 and GE_vB_Pae-Kakheti25. All four 
P. aeruginosa phages [i.e. PNM (105 pfu/PBMC), LUZ19 (105–103 pfu/PBMC), 14-1 (104–103 pfu/PBMC and 
Figure 1. Gene expression analysis of 12 immunity-related genes, assessed by means of RT-qPCR, after 20 h 
stimulation of PBMCs with S. aureus strain ATCC 6538 or S. aureus phage ISP. Comparison of the immune 
response of the PBMCs, expressed as log2 fold change, after normalization with reference gene ACTB, as 
induced by the phage lysate, highly purified phage (undiluted and diluted hundredfold) or its bacterial host 
(i.e. S. aureus strain ATCC 6538). The immune response induced by the highly purified phage preparation 
is stronger than the one induced by the phage lysate. Diluting of the highly purified phage led to an almost 
complete reduction of the observed immune response, with the exception of CXCL5 and IL1B. A strong 
difference is present between the immune response induced by the phage compared to its bacterial host (i.e.  
S. aureus strain 6538).
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Ge_vB_Pae-Kakheti25 (104 pfu/PBMC)] induced a comparable immune response (Fig. 4). For all four phages, 
there is a clear difference in the level of the gene expression induced in the PBMCs by the stimulation of the phage 
lysate or the highly purified phage. For all four phages, the phage lysate induces a stronger immune response 
compared to the highly purified phage.
All four P. aeruginosa phages induce IL6 and the anti-inflammatory genes IL1RN, IL10 and SOCS3, as well as 
the pro-inflammatory genes CXCL1, CXCL5, IL1A and IL1B. Only the expression of TNFA is different between 
the four phages, with phage PNM and 14-1 inducing a significant slight up-regulation while phages LUZ19 and 
GE_vB_Pae-Kakheti25 induced a down-regulation (Fig. 4).
Moreover, the phage lysates strongly resemble the immune response induced by their bacterial host, i.e. P. 
aeruginosa strain 573.
Discussion
Transcriptome analysis of PBMCs stimulated with P. aeruginosa phage PNM showed the differential expression 
of different immunity-related genes. Subsequent in depth analysis of twelve selected immunity-related genes 
(Table S5) by means of RT-qPCR confirmed that five different bacteriophages, one with a Gram-positive host and 
four with a Gram-negative host (Table 1), were able to induce an immune response. Our study addressed only the 
cytokine gene expression level and not the cytokine protein level, for several reasons. First, stimulation times for 
cytokine protein levels are much longer38, 39 and such longer stimulation times are not optimal for freshly isolated 
Figure 2. Gene expression analysis of 12 immunity-related genes, assessed by means of RT-qPCR, after 20 h of 
stimulation of PBMCs with S. aureus phage ISP in combination with endotoxins (i.e. 0.1, 10−3 or 10−7 EU/ml). 
(A,B,C) 103 pfu/PBMC in combination with (A) 0.1 EU/PBMC, (B) 10−3 EU/PBMC or (C) 10−7 EU/PBMC 
leads to an immune response more similar to the one induced by the phage alone. (D,E,F) Reducing the phage 
titer to 10 pfu/PBMC causes the immune response to tilt in the direction of the endotoxin induced immune 
response instead of the phage induced immune response.
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PBMCs. Furthermore, an early response and fluctuations in the response are more rapidly detected at the gene 
transcription level than at changes in protein concentration.
We found that for all five phages, the overall immune response (as determined by RT-qPCR) is very com-
parable (Fig. 5), but differs from the immune response induced by their bacterial host. The observed immune 
response is largely in correspondence with the transcriptome analysis. Moreover, the immune response induced 
by a large number of phages (i.e. 103 pfu/PBMC) seems to be endotoxin independent; the addition of endotox-
ins to the highly purified S. aureus phage ISP did not subvert the immune response to the one induced by the S. 
aureus phage ISP lysate. Furthermore, the stimulation of PBMCs with either a P. aeruginosa phage PNM lysate 
or a highly purified P. aeruginosa phage PNM preparation supplemented with endotoxins in concentration of 0.1 
EU/PBMC (Fig. 3) did not bring the observed immune response closer to the one induced by the phage PNM 
lysate, indicating that the immune response induced by the phage preparations is not due to the presence of 
endotoxins but more due to presence of other bacterial components in the phage lysate preparation. Additionally, 
it has recently been shown that Escherichia coli phage T4 gp12 can decrease the immune response induced by 
endotoxins, through the binding of endotoxins to gp1240.
Whether phages induce a highly comparable overall immune response or whether only specific parts of the 
immune response are similar needs to be further evaluated, as we specifically looked at twelve immunity-related 
genes. However, the ability of these five phages to induce a, largely, similar immune response might be due to the 
modular nature of phage genomes41. Based on the modular nature of phages genomes, it can be hypothesized that 
Figure 3. Effect of endotoxins in the presence P. aeruginosa phage PNM. (A) Gene expression analysis of 12 
immunity-related genes by means of RT-qPCR after 20 h of stimulation of PBMCs. PBMCs were stimulated with 
P. aeruginosa phage PNM, either a phage lysate (105 pfu/PBMC; 0.1 EU/PBMC) or a highly purified phage 
preparation (105 pfu/PBMC; 10−5 EU/PBMC) in combination with 0.1 EU/PBMC. The pro-inflammatory 
markers IL1A, IL1B, CXCL1 and CXCL5, and the anti-inflammatory markers SOCS3, IL10, IL1RN and IL6 are 
upregulated The addition of 0.1 EU/PBMC to the highly purified P. aeruginosa phage preparation does not 
revert the observed immune response to that of the phage lysate for IL10, IL1A, IL6, TNFA and CXCL1. (B) 
Principal components analysis of P. aeruginosa phage PNM with or without the addition of endotoxins. The 
immune response induced by the highly purified phage PNM ( ) differs from the one induced by the phage 
PNM lysate ( ), as these two groups are visibly separated. When endotoxins are added to a final concentration of 
0.1 EU/PBMC to the highly purified phage ( ), the immune response is similar to the highly purified phage ( ) 
and not towards the phage lysate ( ), indicating that the observed difference is not due to the presence of LPS 
but due to bacterial proteins present in the phage lysate.
www.nature.com/scientificreports/
7SCIenTIfIC RePoRts | 7: 8004  | DOI:10.1038/s41598-017-08336-9
phage capsid proteins might have similar folds and subsequently induce similar immune responses. For instance, 
it has been shown that gp23 and gp24 of E. coli phage T4 have a similar fold as that of the E. coli phage HK97 cap-
sid protein42, 43. Yet a single point mutation can change the serotype of the phage. This might also be the case for P. 
aeruginosa phage PNM and LUZ19, which are homologous, yet slightly differ in the induced immune response.
At this point it is difficult to establish whether the phages are predominantly pro- or anti-inflammatory, 
although the phages have the tendency to induce an anti-inflammatory response, as assessed on the basis of these 
twelve immunity-related genes and on the premise of a sufficiently high phage concentration (i.e. 103 pfu/PBMC). 
It is on the other hand very clear that they do activate several immunological pathways (Fig. 6).
The influence of phages on e.g. cytokine mRNA production, as observed in this study, may not be all that 
unexpected, since there are several indications for other interactions of phages with human cells. For example, 
they may play a significant role in transplantation as it was shown that in mice they reduce cellular infiltration 
of allogenic skin allografts44. Phages might do this by inhibiting the adhesion of platelets and, to some extent, of 
T- cells to fibrinogen, a protein which plays an important role in transplant rejection, angiogenesis and metasta-
sis45, 46. A more recent study demonstrated that bacteriophages are also able to inhibit the production of reactive 
oxygen species (ROS) as part of the response of granulocytes to the presence of bacteria, which may be beneficial 
because overproduction of ROS leads to tissue damage47, 48. Another study proved that phages can aid in the kill-
ing of phagocytosed S. aureus49. The authors showed that phage particles absorbed to the bacterial surface have 
an impact on the killing of engulfed S. aureus inside phagocytic cells (e.g. macrophages) by 38.7%. Furthermore, 
it has been indicated that phages are able to interact with human mucosal surfaces and form a non-host derived 
immune barrier50, 51.
It was recently shown that the surface proteins gp23*, gp24*, Hoc and Soc of phage T4 do not induce an 
IL10 response, neither as elements of the integral phage capsid nor as isolated proteins. This is in accordance to 
our findings for S. aureus phage ISP, but not for the P. aeruginosa phages18, 52. Nor did these authors detect the 
presence of pro-inflammatory cytokines such as TNFA, IL1 and IL6 in mice, murine dendritic cell cultures or 
human blood. Contrary to what we show here, they postulate (based on their findings) that bacteriophages do 
not induce an immune response. This difference in results might be explained by the use of different incubation 
times, since we used 20 h as a stimulation time (optimal time frame for the detection of IL10 mRNA) instead of 
5–6 h. Another major difference is that they studied an Escherichia coli phage (T4), which might suggest a species/
phage specific response.
The up-regulation of IL1RN by all five phages, as shown in our study, is of particular interest. All five phages 
induce the pro-inflammatory cytokines IL1A and IL1B, but the simultaneous induction of the anti-inflammatory 
Figure 4. Gene expression analysis of 12 immunity-related genes by means of RT-qPCR after 20 h stimulation 
of PBMCs. PBMCs were stimulated with either (A) P. aeruginosa phage PNM, (B) P. aeruginosa phage LUZ19, 
(C) P. aeruginosa phage 14-1 or (D) P. aeruginosa phage GE_vB_Pae-Kakheti25. The pro-inflammatory 
markers IL1A, IL1B, CXCL1 and CXCL5 and the anti-inflammatory markers SOCS3, IL10, IL1RN and IL6 are 
up-regulated. Only phages PNM (A) and 14-1 (C) slightly up-regulate TNFA, whereas phages LUZ19 (B) and 
GE_vB_Pae-Kakheti25 (D) cause a slight down-regulation of TNFA.
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IL1 receptor antagonist (IL1RN) will interfere with the pro-inflammatory IL1 signal and thus dampen the IL1 
pro-inflammatory response.
In a previous study we showed the difficulty to remove endotoxins from phage preparations53, making it 
impossible to completely remove all endotoxins from high titer P. aeruginosa phage preparations. To exclude that 
the observed immune response for the P. aeruginosa phages were, partially, due to incomplete endotoxin removal, 
we compared the response of S. aureus phage ISP, shown to be completely endotoxin-free with that of ISP phage in 
combination with three concentrations of endotoxins (i.e. 0.1, 10−3 or 10−7 EU/PBMC). Our results strongly indi-
cate that the addition of even the highest concentration of endotoxins to a high concentration of S. aureus phage 
ISP (i.e., 103 pfu/PBMC) has no effect on the induced immune response (Figs 2A and S1). Intriguingly, when an 
intermediate level of endotoxins was added, the immune response tipped to a more anti-inflammatory response 
(i.e. an up-regulation of IL1RN and a strongly reduced expression of CXCL1 and CXCL5) and differed from that 
after stimulation with the highly purified phage or with only endotoxin.
Conclusions
The up-regulation of IL1RN (Interleukin-1 Receptor Antagonist) and SOCS3 (Suppressor of Cytokine Signaling 
3) by all five phages, or the down-regulation of CXCL1 and CXCL5 by S. aureus phage ISP in addition of endotox-
ins, might indicate that these phages have evolved anti-inflammatory properties while some pro-inflammatory 
properties remain (e.g. up-regulation of IL1A, IL1B and TNFA). It could thus be postulated that by reducing 
the immune response, phages first reduce the chance to be removed from the human body and be degraded. 
Secondly, these responses might promote the survival of their bacterial host which in turn provides the phage 
with a higher fitness and better opportunities to proliferate and remove the pathogenic bacteria, in case of bacte-
rial infections. With regard to phage therapy, these anti-inflammatory effects of phages might increase the capac-
ity of the phages to suppress bacterial numbers and thus infections, with the addition of dampening the negative 
side of the inflammatory response.
Material and Methods
Culture of Pseudomonas aeruginosa and Staphylococcus aureus strains. Pseudomonas aeruginosa 
strain 573 (received from the Eliava IBMV, Tbilisi, Georgia) and Staphylococcus aureus strain ATCC 6538 were 
grown on a Lysogeny Broth (LB) agar plates (Becton Dickinson, Erembodegem, Belgium) and incubated over-
night at 37 °C. One colony was subsequently used to inoculate a 15 ml tube containing a 4 ml LB agar slant, and 
incubated again overnight at 37 °C. Five ml saline was added to yield a suspension with a final concentration of 
107 cfu/ml, as confirmed by culture of serial tenfold dilutions.
Figure 5. Principal component analysis (PCA). Comparison of the immune response of PBMCs induced 
by all five tested phages (Highly purified or phage lysate; magenta) and their bacterial host strain (blue). The 
PCA clearly shows that the bacteria (blue) and phages (magenta) for two separate groups, indicating that the 
immune response induced is different between these two types of stimuli. There is no clear distinction between 
the different phages, indicating that these five different phages induced similar responses. Moreover the gene 
expression of IL1RN, IL1B and SOCS3, IL6 and IL1A, TNFA and IL10, and LYZ and TGFBI are correlated.
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Bacteriophage preparation. Phage propagation. Bacteriophage stocks (Table 1) were prepared using the 
double-agar overlay method as described in Merabishvili et al.54. Briefly, one ml of phage preparation contain-
ing 106 plaque forming units (pfu) of bacteriophages was mixed with 3 ml of molten (45 °C) LB top Bacto agar 
(0.6%) (Becton Dickinson) and 100 µl of the host strain suspension (end concentration of 107 cfu/ml) in a sterile 
14 ml tube (Falcon, Becton Dickinson). This mixture was plated onto freshly made 90 mm diameter Petri dishes 
(Plastiques Gosselin, Menen, Belgium), filled with a bottom layer (20 ml) of 1.5% LB agar, and incubated aerobi-
cally at 32 °C for 16 h. Subsequently, 200 µl of chloroform was added to the lids of the Petri dishes and the inverted 
plates were further incubated at 4 °C for 1 h. The top layer of the double-agar layer was scraped off using a sterile 
Drigalski spatulum and transferred to a sterile 50 ml tube.
The harvested phages were centrifuged for 20 min at 6,000 × g at 4 °C. The supernatant was aspirated using 
a sterile 10 ml syringe (BD Plastipak, Becton Dickinson) with a 30G sterile needle (BD Microlance 3, Becton 
Dickinson) and passed through a 0.22 µm membrane filter (Sartorius Stedim, Zellik, Belgium). The filtrate was 
subsequently centrifuged at 35,000 × g for one hour. The phage pellet was resuspended in 5 ml saline and stored 
at 4 °C overnight before determining the phage titer. Preferably, the titer of the phage lysate should be checked 
at least one day later according to the above described procedures. This will allow phage particles that may have 
clumped together during centrifugation steps to disengage21.
Phage titer determination. The bacteriophage titer was determined by assaying decinormal serial dilutions 
(log(0) to log(−12)) of the bacteriophage suspension with the overlay method54. One ml of each dilution was 
mixed with 3 ml of molten (45 °C) LB 0.6% top Bacto agar and the host strain (end concentration of 107 cfu/ml) 
in a sterile 14 ml tube. This mixture was plated in triplicate onto 90 mm diameter Petri dishes, filled with a bottom 
layer of 1.5% LB agar, and incubated for 16 h at 37 °C. To determine the original bacteriophage concentration, 
plates with one to 100 distinguishable plaques were counted. The mean was then calculated for the triplicate 
plates.
Figure 6. Hypothetical view of the interaction of bacteriophages with mammalian immune cells. Phages are 
able to interact with (currently unknown) immune receptors and induce corresponding immune responses. 
The immune responses induced by the bacteriophages can either be pro- of anti-inflammatory. For instance, 
the tested phages are able to induce the pro-inflammatory cytokines IL1α and IL1β. Through the induction of 
IL1RN by the phage, the phage is able to inhibit the pro-inflammatory responses that are otherwise induced 
by these cytokines. Pro-inflammatory cytokines are marked in red (i.e. TNF-α, IFN-γ,IL1α, IL1β, IL-6, IL-17, 
CXCL1 and CXCL5), anti-inflammatory cytokines are depicted in green (i.e. TGF-β, IL-4, IL-10 and IL1RN). 
Dark orange depicts proteins that play a key role in the removal or perception of bacterial pathogens (i.e. CD14 
and LYZ).
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Endotoxin removal. Endotoxins were removed and quantified as described in Van Belleghem et al.53. Briefly, 
phage lysates were further purified using CsCl centrifugation. Subsequently, endotoxin concentrations were 
determined using the EndoZyme recombinant Factor C (rFC) Assay (Hyglos, Bernried am Starnberger See, 
Germany). For the P. aeruginosa phages, 10−5–10−10 EU/pfu remained after the CsCl purification. The S. aureus 
phage ISP contained no endotoxins (Table 1).
PBMC isolation. Peripheral Blood Mononuclear Cells (PBMCs) were isolated from a buffycoat after 
informed consent (Blood Transfusion Centre, Ghent), using a Lymphoprep (Axis-Shield, Dundee, Scotland) 
gradient. Fifty ml of the buffycoat was added to 250 ml Hank’s Balanced Salt Solution, without Ca2+ and Mg2+ 
(HBSS) (Invitrogen). Of this dilution, eight aliquots of 35 ml were each added to 15 ml Lymphoprep in a 50 ml 
Falcon tube. These mixtures were subsequently centrifuged at 500 x g for 20 min at room temperature. The inner 
whitish ring of PBMCs, present between the lymphoprep and the plasma phase, was transferred to 25 ml HBSS 
and centrifuged at 450 × g for 10 min at room temperature. The supernatants was removed and the cell pellet was 
resuspended in 10 ml HBSS. All resuspended cells were pooled into a 50 ml Falcon tube and HBSS was added to 
a total volume of 50 ml. A small fraction of this cell solution was used to count the number of cells present, before 
it was centrifuged again at 350 × g for 10 min at room temperature.
The total number of cells was counted using a Sysmex KX-21 (Sysmex, Norderstedt, Germany). The cell pellet 
was resuspended in heat-inactivated foetal calf serum with 10% dimethyl sulfoxide (DMSO) to a concentration 
of 2 × 107 cells/ml and divided in 1 ml aliquots before cryostorage them in liquid nitrogen.
Stimulation of PBMCs. Stimulations were performed in 100 µl volumes containing 106 PBMCs. One vial 
of stored PBMCs, containing 2 × 107 cells/ml, was thawed at 37 °C prior to adding 9 ml HBSS (without Ca2+ and 
Mg2+). This suspension was subsequently centrifuged at 350 × g for 10 min. The obtained cell pellet was resus-
pended in 5 ml HBSS (without Ca2+ and Mg2+) and 80 µl was used for cell counting on a Sysmex KX-21. This 
cell suspension was centrifuged at 350 × g for 10 min. The resulting cell pellet was resuspended in RPMI 1640 
(supplemented with 2 mM L-glutamic acid, 1X MEM non-essential amino acids, 1 mM sodium pyruvate, 60 U of 
penicillin/ml, 10 mg/ml streptomycin, 2 mM L-glutamine and 10% heat inactivated foetal calf serum) to a final 
concentration of 107 cells/ml55.
The PBMCs (i.e. 106 PBMCs/100 µl) were subsequently stimulated with 10 µl of the bacterial host (i.e. either 
P. aeruginosa or S. aureus, at a concentration of 107 cfu/ml, i.e., 105 cfu per 106 PBMC or 0.1 cfu/PBMC), 10 µl of 
the phage suspensions (i.e. either a phage lysate or a highly purified (CsCl) phage suspension (Table 1)) at con-
centrations between 1013 and 109 pfu/ml, i.e., 105 or 10 pfu/PBMC, or phage suspension in combination with 10 µl 
endotoxins (commercial preparation derived from P. aeruginosa strain 10; Sigma Aldrich) at concentrations of 
101, 105 or 107 Endotoxin units/ml (EU/ml), i.e., 0.1, 10−3 or 10−7 EU/PBMC. As a negative control, 10 µl saline 
was added to the cells. The PBMCs were incubated for 20 h at 37 °C in 5% CO2. All stimulation experiments and 
controls were carried out on six biological replicates (i.e. anonymous donors) in triplicate. We confirm that all 
methods were carried out in accordance to relevant guidelines and regulations and that all experimental protocols 
were approved by the ethical committee of the university of Ghent (EC/2017/0558).
Extraction of total nucleic acids. After 20 h of PBMC stimulation, the total cell volume was transferred to 1 ml 
Qiazol (Qiagen, Valencia, CA) and stored at −80 °C for at least 16 h before extracting the RNA. The total RNA 
fraction was isolated using a semi-automated procedure of NucliSens EasyMag (Biomérieux, Marcy l’Étoile, 
France). Briefly, 900 µl EasyMag lysis buffer was added to the 1.1 ml Qiazol solution. This mixture was subse-
quently transferred to an NucliSens EasyMag cartridge. Finally, 100 µl magnetized silica was added and the car-
tridge was loaded on the machine (according to the manufacturer). In a final step, the RNA was eluted with 35 µl 
NucliSens EasyMag elution buffer.
DNase digest. DNase digest was performed immediately after nucleic acid extraction to remove DNA from the 
sample. Five µl of the nucleic extract was added to one µl of DNase (1 U/µl), one µl 10X DNase reaction buffer 
(Promega, Mannheim, Germany) and three µl of RNase free H2O to make up a total volume of 10 µl. This mixture 
was incubated for 30 min at 37 °C. The DNase digestion was terminated by adding 1 µl of DNase Stop Solution and 
incubating the mixture at 65 °C for 10 min. DNase digested RNA samples were stored at −80 °C.
cDNA Library preparation and sequencing. For transcriptome analysis purposes: cDNA preparation and Illumina 
HiSeqTM sequencing was performed at the Beijing Genome Institute (BGI) as described by Ren et al.56. The cDNA 
libraries were prepared according to the manufacturer’s instructions (Illumina, San Diego, CA). Beads coated 
with oligo(dT) were used to isolate eukaryotic poly(A) mRNA from the total RNA. Purified mRNA was then 
fragmented in RNA fragmentation buffer (Ambion, Austin, TX). Using these short fragments as templates, ran-
dom hexamer-primers (Illumina) were used to synthesize the first-strand cDNA. The second-strand cDNA was 
synthesized using buffer, dNTPs, RNase H and DNA polymerase I. Short double-stranded cDNA fragments were 
purified with a QIAquick PCR extraction kit (Qiagen) and eluted with elution buffer for end repair and the addi-
tion of a terminal ‘A’ nucleotide. Next, Illumina sequencing adaptors were ligated to the DNA fragments. DNA 
fragments of a selected size were gel-purified and amplified by PCR. The amplified library was sequenced on an 
Illumina HiSeqTM 2000 sequencing machine at BGI, using single-end sequencing with an expected library size of 
160 bp and a read length of 90 nt.
For RT-qPCR purposes: The cDNA synthesis was preformed using the RevertAid RT kit (Thermo Scientific, 
Waltham, MA) in four times 40 µl volumes according to the manufacturer’s instructions.
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Raw read filtering, mapping expression quantification. The images generated by the sequencer were converted 
into nucleotide sequences by a base-calling pipeline. The raw reads were saved in fastq format, and the dirty raw 
reads were removed prior to analyzing the data. Dirty raw reads were removed according to the following criteria: 
reads with sequence adaptors, reads with more than 10% ‘N’ bases; low quality reads (i.e. the percentage of low 
quality bases is over 50% in a read, BGI defined the low quality base to be the base whose sequencing quality is no 
more than 10). All subsequent analyses were based on clean reads.
The reference sequences used were human genome and transcriptome sequences downloaded from the UCSC 
website (version hg19). Clean reads were respectively aligned to the reference genome and transcriptome using 
SOAP257. No more than three mismatches were allowed in the alignment for each read.
Reads that could be uniquely mapped to a gene were used to calculate the expression level. The gene expres-
sion level was measured by the number of uniquely mapped reads per kilobase of exon region per million map-
pable reads (RPKM)58.
Differentially expressed gene (DEG) analysis. Using ‘The significance of digital gene expression profiles’59, differ-
entially expressed genes between P. aeruginosa-stimulated PBMCs and non-stimulated PBMCs were identified, 
based on the following criteria: False Discovery Rate (FDR) ≤0.001 and an absolute fold change ≥2. The data dis-
cussed in this publication have been deposited in NCBI’s Gene Expression Omnibus60 and are accessible through 
GEO Series accession number GSE95573 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE95573).
Expression pattern analysis of DEGs. Based on the assumption that genes that have a similar expression pattern 
usually have a functional correlation, cluster analysis of gene expression patterns was performed using the clus-
ter61 and javaTreeview62 software.
Gene ontology (GO) analysis of DEGs. The gene ontology analysis of DEGs was performed by a GO enrichment 
analysis, which provides all GO terms that are significantly enriched in a list of DEGs by comparing to a genome 
background and subsequent filtering the DEGs that correspond to specific biological functions. In this method 
all DEGs are first mapped to GO terms in the GO database (http://www.geneontology.org), calculating gene num-
bers for every term, then using hypergeometic tests to find significantly enriched GO terms in the input list of 
DEGs, based on ‘GE::TermFinder’ (http://smd.stanford.edu/help/GO-TermFinder/GO_TermFinder_help.shtml).
Gene expression analysis of 12 immunity-related genes. RT-qPCR. Based on the RNA seq data, 
twelve target genes were selected for further evaluation by RT-qPCR. Combining the datasets of both the phage 
PNM lysate and P. aeruginosa stimulated PBMCs, we observed that a total of 2679 genes were uniquely expressed. 
As a cut-off for qPCR detection, a minimum of 7000 reads was selected either in the control condition or after 
stimulation, to ensure detection in the RT-qPCR. This led to a reduction to 418 genes. Furthermore, to detect 
a difference in gene expression in the qPCR, a Log2Fold change difference was needed after normalization of 
the target genes by the reference gene ACTB. This led to a further reduction to 176 potential target genes for 
qPCR-based analysis. From these, a total of twelve genes were selected on the basis of their possible importance 
in the immune response, i.e CD14, CXCL1, CXCL5, IL1A, IL1B, IL1RN, IL6, IL10, LYZ, SOCS3, TGFBI and TNFA 
(Table S6).
The RT-qPCR was performed in a total reaction volume of 10 µl using 0.5 µM of each primer (Table S5), 2.5 µl 
cDNA and LightCycler 480 High resolution Melting master (Roche Applied Sciences, Indianapolis, Indiana).
The selection of the most stable reference gene(s) was carried out as described by Vandesompele et al.63 using 
SybrGreen as means of detection. Using geNorm, we found that all six reference genes (i.e. ACTB, GADPH, 
HRPT1, PPIA, TBP and UBC; Table S7) are sufficiently stable (internal control gene-stability measure M < 1.5). 
Therefore, the minimal optimal number of reference targets to be used in this experiment was 1 (V < 0.15).
The mRNA levels are expressed in relative copy numbers normalized against the reference gene (ACTB), as 
described by Giulietti et al.64 and Samarasinghe et al.65.
Importance. We show that bacteriophages are able to induce an (innate) immune response, in contrast to 
some other recent reports. Additionally, we have strong indications that the phage-induced response is overall 
anti-inflammatory, which may contribute to the beneficial therapeutic effects of phages during phage therapy.
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